CEP55 and prostate adenocarcinoma: Furthermore, CEP55 expression was considerably higher in cancer tissues than in the corresponding tumor-adjacent normal tissues in 17 cancers: BRCA, BLCA, CHOL, ESCA, COAD, HNSC, KICH, KIRP, KIRC, LIHC, LUSC, LUAD, prostate adenocarcinoma (PRAD), STAD, READ, THCA, and UCEC (Figure 2B).